TP53 and Alzheimer disease: According to reports in the literature and our earlier investigations, the highest levels of 8-oxo-2′dG and TP53 occur in the early stages of AD and then tend to decrease during the neurodegenerative process of developing dementia, probably due to oxidative modifications leading to changes in the activity of the TP53 protein [34,113].